PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 21, 2026Clinical and Experimental Dermatology0 citations

Safety and efficacy of intralesional Amphotericin B in the treatment of Old World Cutaneous Leishmaniasis: A non-randomized open-label prospective study

View Full Paper
SMSabha MushtaqDDDevraj DograNDNaina Dogra

Key Points

  • The aim is to evaluate the safety and efficacy of intralesional amphotericin B for treating Old World cutaneous leishmaniasis.
  • Conducted a non-randomized prospective study
  • Administered intralesional amphotericin B deoxycholate
  • Evaluated treatment outcomes in patients with Old World cutaneous leishmaniasis
  • Intralesional amphotericin B demonstrated effectiveness in treating Old World cutaneous leishmaniasis
  • The treatment was found to be safe despite the limitations of small sample size and lack of control group

Abstract

Intralesional amphotericin B deoxycholate was found to be effective and safe in the treatment of OWCL. The study is limited by the small sample size, lack of a control group and non-availability of species typing.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Mushtaq et al. (2026) studied this question.

synapsesocial.com/papers/69be38596e48c4981c678b7ehttps://doi.org/10.1093/ced/llag136
Ask AI
Helpful
Bookmark
Share
View Full Paper